Qingdao Baheal Medical INC. Cash Flow-to-Debt Ratio
Qingdao Baheal Medical INC. cash flow-to-debt ratio. Qingdao Baheal Medical INC. (301015) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥230.38 Million could theoretically repay 0% of its total liabilities (CN¥4.83 Billion) in one year. Check Qingdao Baheal Medical INC. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Qingdao Baheal Medical INC. (2018–2025)
Cash flow-to-debt ratio of Qingdao Baheal Medical INC. from 2018 to 2025. Historical debt coverage capacity for Qingdao Baheal Medical INC. across 8 annual periods. Check Qingdao Baheal Medical INC. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Qingdao Baheal Medical INC. Cash Flow-to-Debt Ratio by Year (2018–2025)
Qingdao Baheal Medical INC. cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Qingdao Baheal Medical INC.. For the full cash flow conversion analysis, see Qingdao Baheal Medical INC. (301015) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥934.45 Million | CN¥5.37 Billion | ▼ -3.6% |
| 2024 | 0.18x | CN¥813.85 Million | CN¥4.51 Billion | ▼ -25.5% |
| 2023 | 0.24x | CN¥799.50 Million | CN¥3.30 Billion | ▲ +124.8% |
| 2022 | 0.11x | CN¥305.75 Million | CN¥2.84 Billion | ▲ +44.4% |
| 2021 | 0.07x | CN¥181.30 Million | CN¥2.43 Billion | ▲ +263.0% |
| 2020 | -0.05x | CN¥-116.83 Million | CN¥2.55 Billion | ▼ -311.6% |
| 2019 | 0.02x | CN¥45.96 Million | CN¥2.12 Billion | ▼ -39.9% |
| 2018 | 0.04x | CN¥55.50 Million | CN¥1.54 Billion | — |